For example, elevating miR-107 levels in MiaPACA-2 and PANC-1 cells led to reduced cell growth in vitro, linked to the suppression of cyclin-dependent kinase 6 (CDK6), a potential target of miR-107 in pancreatic cancer (Lee et al. 2009). This evidence concerns the gene CDK6 and pancreatic neoplasm.